NO20052108L - Terapeutiske peptider. - Google Patents
Terapeutiske peptider.Info
- Publication number
- NO20052108L NO20052108L NO20052108A NO20052108A NO20052108L NO 20052108 L NO20052108 L NO 20052108L NO 20052108 A NO20052108 A NO 20052108A NO 20052108 A NO20052108 A NO 20052108A NO 20052108 L NO20052108 L NO 20052108L
- Authority
- NO
- Norway
- Prior art keywords
- ligand
- present
- provides
- therapeutic peptides
- product
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 241000588655 Moraxella catarrhalis Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer en ligand isolert fra Moraxella catarrhalis-yttermembranprotein som binder til CEACAM-reseptorer, der nevnte ligand omfatter et reseptorbindende domene omfattende en aminosyresekvens valgt fra gruppen beskrevet, eller et fragment, homolog, funksjonell ekvivalent, derivat, degenerat eller hydroksylerings-, sulfonerings- eller glykosyleringsprodukt eller annet sekundært prosesseringsprodukt derav. Foreliggende oppfinnelse tilveiebringer også medikamenter og vaksiner omfattende nevnte ligand og anvendelse av dem i behandling eller profylakse av infeksjon. Også fremskaffet er en screenings-fremgangsmåte for identifisering av nye terapeutiske forbindelser.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222764.3A GB0222764D0 (en) | 2002-10-02 | 2002-10-02 | Therapeutic peptide |
| PCT/GB2003/004273 WO2004031236A2 (en) | 2002-10-02 | 2003-10-01 | Therapeutic uspa1-derived peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052108D0 NO20052108D0 (no) | 2005-04-29 |
| NO20052108L true NO20052108L (no) | 2005-06-27 |
Family
ID=9945111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052108A NO20052108L (no) | 2002-10-02 | 2005-04-29 | Terapeutiske peptider. |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP1546194B1 (no) |
| JP (1) | JP4763291B2 (no) |
| KR (1) | KR101057587B1 (no) |
| CN (1) | CN1305899C (no) |
| AT (1) | ATE549348T1 (no) |
| AU (1) | AU2003299131B2 (no) |
| BR (1) | BR0315031A (no) |
| CA (1) | CA2500960A1 (no) |
| ES (1) | ES2383958T3 (no) |
| GB (1) | GB0222764D0 (no) |
| HK (1) | HK1076475A1 (no) |
| IL (1) | IL167780A (no) |
| MX (1) | MXPA05003474A (no) |
| NO (1) | NO20052108L (no) |
| NZ (1) | NZ539575A (no) |
| PL (1) | PL376052A1 (no) |
| WO (1) | WO2004031236A2 (no) |
| ZA (1) | ZA200503446B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2563332A1 (en) * | 2004-04-15 | 2005-10-27 | The University Of Bristol | Therapeutic uspa1-derived peptides |
| KR20080042865A (ko) * | 2005-08-10 | 2008-05-15 | 아르네 포르스그렌 아베 | 모락셀라 카타랄리스와 상피세포, 세포외기질 단백질 및보체계의 상호작용 |
| TW201302779A (zh) | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515467A (ja) * | 1996-12-20 | 2001-09-18 | ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム | モラクセラ・カタラーリスのｕｓｐａ１及びｕｓｐａ２抗原 |
-
2002
- 2002-10-02 GB GBGB0222764.3A patent/GB0222764D0/en not_active Ceased
-
2003
- 2003-10-01 CN CNB2003801017669A patent/CN1305899C/zh not_active Expired - Fee Related
- 2003-10-01 PL PL03376052A patent/PL376052A1/xx not_active IP Right Cessation
- 2003-10-01 CA CA002500960A patent/CA2500960A1/en not_active Abandoned
- 2003-10-01 KR KR1020057005764A patent/KR101057587B1/ko not_active IP Right Cessation
- 2003-10-01 BR BR0315031-3A patent/BR0315031A/pt not_active IP Right Cessation
- 2003-10-01 NZ NZ539575A patent/NZ539575A/en not_active IP Right Cessation
- 2003-10-01 EP EP03756554A patent/EP1546194B1/en not_active Expired - Lifetime
- 2003-10-01 ES ES03756554T patent/ES2383958T3/es not_active Expired - Lifetime
- 2003-10-01 EP EP10177682A patent/EP2305700A1/en not_active Withdrawn
- 2003-10-01 AT AT03756554T patent/ATE549348T1/de active
- 2003-10-01 WO PCT/GB2003/004273 patent/WO2004031236A2/en active Application Filing
- 2003-10-01 MX MXPA05003474A patent/MXPA05003474A/es active IP Right Grant
- 2003-10-01 AU AU2003299131A patent/AU2003299131B2/en not_active Ceased
- 2003-10-01 JP JP2004540969A patent/JP4763291B2/ja not_active Expired - Fee Related
-
2005
- 2005-03-31 IL IL167780A patent/IL167780A/en not_active IP Right Cessation
- 2005-04-29 ZA ZA200503446A patent/ZA200503446B/en unknown
- 2005-04-29 NO NO20052108A patent/NO20052108L/no not_active Application Discontinuation
- 2005-09-24 HK HK05108446.8A patent/HK1076475A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101057587B1 (ko) | 2011-08-19 |
| JP4763291B2 (ja) | 2011-08-31 |
| ES2383958T3 (es) | 2012-06-27 |
| CN1705678A (zh) | 2005-12-07 |
| HK1076475A1 (en) | 2006-01-20 |
| CN1305899C (zh) | 2007-03-21 |
| EP1546194B1 (en) | 2012-03-14 |
| MXPA05003474A (es) | 2005-10-18 |
| ATE549348T1 (de) | 2012-03-15 |
| IL167780A (en) | 2011-05-31 |
| AU2003299131B2 (en) | 2010-04-22 |
| BR0315031A (pt) | 2005-08-16 |
| EP1546194A2 (en) | 2005-06-29 |
| AU2003299131A1 (en) | 2004-04-23 |
| ZA200503446B (en) | 2006-10-25 |
| NZ539575A (en) | 2006-06-30 |
| CA2500960A1 (en) | 2004-04-15 |
| EP2305700A1 (en) | 2011-04-06 |
| GB0222764D0 (en) | 2002-11-06 |
| WO2004031236A3 (en) | 2004-06-24 |
| WO2004031236A2 (en) | 2004-04-15 |
| PL376052A1 (en) | 2005-12-12 |
| JP2006516952A (ja) | 2006-07-13 |
| KR20050067410A (ko) | 2005-07-01 |
| NO20052108D0 (no) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karamloo et al. | Prevention of allergy by a recombinant multi‐allergen vaccine with reduced IgE binding and preserved T cell epitopes | |
| Prasad et al. | Presentation of cryptic peptides by MHC class I is enhanced by inflammatory stimuli | |
| Scholzen et al. | Promiscuous Coxiella burnetii CD4 epitope clusters associated with human recall responses are candidates for a novel T-cell targeted multi-epitope Q fever vaccine | |
| Maeda et al. | Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein | |
| Crowe et al. | Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity | |
| Zhang et al. | Tongue sole (Cynoglossus semilaevis) prothymosin alpha: Cytokine-like activities associated with the intact protein and the C-terminal region that lead to antiviral immunity via Myd88-dependent and-independent pathways respectively | |
| Tanaka et al. | Micrurus snake species: venom immunogenicity, antiserum cross-reactivity and neutralization potential | |
| Pérez-Sánchez et al. | Function-guided selection of midgut antigens from Ornithodoros erraticus ticks and an evaluation of their protective efficacy in rabbits | |
| NO20052108L (no) | Terapeutiske peptider. | |
| Davis et al. | Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans | |
| CA3232870A1 (en) | Coronavirus vaccines and methods of use | |
| NO20065201L (no) | terapeutiske peptider | |
| Parra et al. | Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein | |
| WO1998029444A1 (en) | Broad spectrum pyrogenic exotoxins antagonists and vaccines | |
| Mori et al. | Two novel Salp15‐like immunosuppressant genes from salivary glands of Ixodes persulcatus Schulze tick | |
| BRPI0516933A (pt) | métodos para o isolamento da haptoglobina humana, dos isoformas de hp humana individuais, e da albumina e da haptoglobina humana a partir da fração v de cohn humana, e, produto | |
| Yang et al. | Differential expression of a putative CarD-like transcriptional regulator, LtpA, in Borrelia burgdorferi | |
| Pedersen et al. | Signal transduction by the major histocompatibility complex class I molecule | |
| EP2888365A1 (en) | A novel toxin in type a clostridium perfringens | |
| WO2022131832A1 (ko) | 신규 코로나바이러스 예방 및 치료용 백신 조성물 | |
| Huo et al. | Molecular cloning of chicken IL-7 and characterization of its antiviral activity against IBDV in vivo | |
| Bui et al. | Type 1 secretion system and effectors in Rickettsiales | |
| Pruksaphon et al. | Immunogenicity of snake α-neurotoxins and the CD4 T cell epitopes | |
| CA2901333A1 (en) | Novel toxins in type a clostridium perfringens | |
| Campbell et al. | Identification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |